Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland

The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland

(2013) Heini Salo et al.   INTERNATIONAL JOURNAL OF CANCER

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland

(2012) M. K. Leinonen et al.   BMJ-British Medical Journal

Self-sample HPV Tests As an Intervention for Nonattendees of Cervical Cancer Screening in Finland: a Randomized Trial

(2011) A. Virtanen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Matti Lehtinen et al.   LANCET ONCOLOGY

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document

(2010) M. Arbyn et al.   ANNALS OF ONCOLOGY

Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached?

(2010) Inge M.C.M. de Kok et al.   INTERNATIONAL JOURNAL OF CANCER

Self-sampling versus reminder letter: Effects on cervical cancer screening attendance and coverage in Finland

(2010) Anni Virtanen et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

(2010) Nubia Muñoz et al.   JNCI-Journal of the National Cancer Institute

Process performance of cervical screening programmes in Europe

(2009) Guglielmo Ronco et al.   EUROPEAN JOURNAL OF CANCER

Cervical cancer screening policies and coverage in Europe

(2009) Ahti Anttila et al.   EUROPEAN JOURNAL OF CANCER